Mcl-1 is implicated in resistance towards ABT-199 in MM and so we reasoned that dual-inhibition of Bcl-2 and Mcl-1 would be more lethal to MM cells vs. inhibition of Bcl-2 or Mcl-1 alone. The gene discussed is MCL1; the disease is Miyoshi myopathy.